Sumatriptan succinate and Raynaud's phenomenon aggravated - a phase IV clinical study of FDA data

Summary:

Raynaud's phenomenon aggravated is reported as a side effect among people who take Sumatriptan succinate (sumatriptan succinate), especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months also take Xyrem, and have Narcolepsy.

The phase IV clinical study analyzes which people have Raynaud's phenomenon aggravated when taking Sumatriptan succinate. It is created by eHealthMe based on reports of 9,380 people who have side effects when taking Sumatriptan succinate from the FDA, and is updated regularly.

What is Sumatriptan succinate?

Sumatriptan succinate has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 9,731 Sumatriptan succinate users. Check the latest studies of Sumatriptan succinate.

What is Raynaud's phenomenon aggravated?

Raynaud's phenomenon aggravated (discoloration of the fingers, toes, and occasionally other areas) is found to be associated with 664 drugs and 350 conditions by eHealthMe. Check the latest studies of Raynaud's phenomenon aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

9,380 people reported to have side effects when taking Sumatriptan succinate.
Among them, 20 people (0.21%) have Raynaud's phenomenon aggravated.

Could Sumatriptan succinate cause Raynaud's phenomenon aggravated?

Among these 20 people:

How long have people been on Sumatriptan succinate when they have Raynaud's phenomenon aggravated? *

What is the gender of people who have Raynaud's phenomenon aggravated when taking Sumatriptan succinate? *

female: 87.5 %
male: 12.5 %

What is the age of people who have Raynaud's phenomenon aggravated when taking Sumatriptan succinate? *

What are other drugs people take besides Sumatriptan succinate? *

What are other side effects people have besides Raynaud's phenomenon aggravated? *

Chest Pain: 6 people, 30.00%
Hypoaesthesia (reduced sense of touch or sensation): 6 people, 30.00%
Acne (skin problems that cause pimples): 4 people, 20.00%
Skin Discoloration - Bluish (bluish colour of skin): 4 people, 20.00%
Pain: 4 people, 20.00%
Pain In Extremity: 4 people, 20.00%
Peripheral Arterial Occlusive Disease (reproducible ischemic muscle pain): 4 people, 20.00%
Mobility Decreased (ability to move is reduced): 4 people, 20.00%
Peripheral Ischaemia (impaired circulation to an extremity): 4 people, 20.00%
Peripheral Vascular Disorder: 4 people, 20.00%

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 30.00%
Drowsiness: 4 people, 20.00%
Cluster Headache (one-sided head pain with tearing): 4 people, 20.00%
Serum Ferritin Decreased: 2 people, 10.00%
Oedema (fluid collection in tissue): 2 people, 10.00%
Multiple Allergies (allergy to multiple agents): 2 people, 10.00%
Depressed Level Of Consciousness: 2 people, 10.00%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 10.00%
Suppressed Lactation: 1 person, 5.00%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Sumatriptan succinate and have Raynaud's phenomenon aggravated?

- Check whether Raynaud's phenomenon aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sumatriptan succinate:

Sumatriptan succinate (9,731 reports)

Browse all side effects of Sumatriptan succinate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Raynaud's phenomenon aggravated:

Raynaud's phenomenon aggravated (664 drugs)

Browse all the conditions that are associated with Raynaud's phenomenon aggravated:

Raynaud's phenomenon aggravated (350 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sumatriptan succinate (the active ingredients of Sumatriptan succinate) and Sumatriptan succinate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.